Health Canada approves SC rituximab for CLLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyAggressive Lymphomas
FDA approves BV plus chemo for untreated cHLMarch 21, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Researchers question validity of NCCN guidelinesMarch 8, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingPediatricsPharmacy
FDA approves label update for nivolumabMarch 8, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
EC approves emicizumab for hemophilia A with inhibitorsMarch 2, 2018ThrombosisPharmacyBleeding Disorders
CHMP recommends approval for GO in AMLMarch 1, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Company withdraws application for idelalisibMarch 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
CHMP endorses drug delivery systemMarch 1, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyRelated Issues
CHMP backs bosutinib for newly diagnosed CMLFebruary 28, 2018Leukemia, Myelodysplasia, TransplantationPharmacyCML
Azacitidine now available in ChinaFebruary 9, 2018AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome
